Dr. Rajeev Saggar - 15 Dec 2023 Form 4 Insider Report for Liquidia Corp (LQDA)

Role: Chief Medical Officer
Signature: /s/ Dr. Rajeev Saggar
Issuer symbol: LQDA
Transactions as of: 15 Dec 2023
Net transactions value: +$110,462
Form type: 4
Filing time: 18 Dec 2023, 20:58:08 UTC
Previous filing: 13 Jan 2023
Next filing: 16 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LQDA	Common Stock	Sale	$110,462	+14,887	+10%	$7.42	164,099	18 Dec 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 18, 2022, the Reporting Person was awarded an aggregate of 93,834 restricted stock units ("RSUs"), all of which, including the unvested portion, were reported on a Form 4 filed on July 20, 2022. The vesting of 52,782 of those previously reported RSUs was deferred until December 14, 2023. As reported on this Form 4, only the requisite amount of shares were sold to cover the required taxes in connection with the vesting and settlement of the 52,782 previously reported RSUs.
F2	Includes (i) 93,384 RSUs granted to the Reporting Person on July 18, 2022, of which 52,782 have vested as of the date of this Form 4, (ii) 83,333 RSUs granted to the Reporting Person on January 11, 2023, none of which have vested as of the date of this Form 4 and (iii) 1,819 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan on August 31, 2023.

Content

On July 18, 2022, the Reporting Person was awarded an aggregate of 93,834 restricted stock units ("RSUs"), all of which, including the unvested portion, were reported on a Form 4 filed on July 20, 2022. The vesting of 52,782 of those previously reported RSUs was deferred until December 14, 2023. As reported on this Form 4, only the requisite amount of shares were sold to cover the required taxes in connection with the vesting and settlement of the 52,782 previously reported RSUs.

Includes (i) 93,384 RSUs granted to the Reporting Person on July 18, 2022, of which 52,782 have vested as of the date of this Form 4, (ii) 83,333 RSUs granted to the Reporting Person on January 11, 2023, none of which have vested as of the date of this Form 4 and (iii) 1,819 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan on August 31, 2023.